A friend of mine did a bit of an analysis on the trading pattern for Prima from 1 Sept2009 to 1 Nov2009. The pattern emerging from the analysis is that the average volume over the period shows that on sp up days the average volume is significantly greater than on share price steady days and significantly greater than on sp down days. Even with the prevailing current lower volumes the average volume is greater on up days than on down days.
People can draw there own conclusions if this has any bearings on proceedings. My own interpretation is that people have been buying the stock in greater numbers when it moves up and selldowns involve a much lower turnover. This to me means that shareholders are not dumping into lower prices and that there is sustained higher buying pressure at times, that pushes the sp up. It looks like the stock is treading water at the moment pending the spp being out of the way and also pending news on phase2 trial progress.
- Forums
- ASX - By Stock
- IMM
- trading analysis is prr positive
IMM
immutep limited
Add to My Watchlist
2.00%
!
24.5¢

trading analysis is prr positive
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $357.7M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 24.0¢ | $419.2K | 1.737M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 301706 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 28117 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 301706 | 0.240 |
6 | 305882 | 0.235 |
11 | 330086 | 0.230 |
13 | 511200 | 0.225 |
17 | 1170248 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 28117 | 2 |
0.250 | 161392 | 6 |
0.255 | 114804 | 6 |
0.260 | 268899 | 9 |
0.265 | 486184 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online